Cong X - Search Results

1

Correction to Design of Bcl-2 and Bcl-xL Inhibitors with Subnanomolar Binding Affinities Based upon a New Scaffold.

Zhou H, Chen J, Meagher JL, Yang CY, Aguilar A, Liu L, Bai L, Cong X, Cai Q, Fang X, Stuckey JA, Wang S. Zhou H, et al. Among authors: cong x. J Med Chem. 2012 Jun 28;55(12):5987. doi: 10.1021/jm300728g. Epub 2012 Jun 7. J Med Chem. 2012. PMID: 22676037 Free PMC article. No abstract available.

2

Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold.

Zhou H, Chen J, Meagher JL, Yang CY, Aguilar A, Liu L, Bai L, Cong X, Cai Q, Fang X, Stuckey JA, Wang S. Zhou H, et al. Among authors: cong x. J Med Chem. 2012 May 24;55(10):4664-82. doi: 10.1021/jm300178u. Epub 2012 May 10. J Med Chem. 2012. PMID: 22448988 Free PMC article.

3

Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity.

Zhou H, Aguilar A, Chen J, Bai L, Liu L, Meagher JL, Yang CY, McEachern D, Cong X, Stuckey JA, Wang S. Zhou H, et al. Among authors: cong x. J Med Chem. 2012 Jul 12;55(13):6149-61. doi: 10.1021/jm300608w. Epub 2012 Jul 2. J Med Chem. 2012. PMID: 22747598 Free PMC article.

4

Design, synthesis and evaluation of highly selective pyridone-based class II MET inhibitors.

She N, Zhuo L, Jiang W, Zhu X, Wang J, Ming Z, Zhao X, Cong X, Huang W. She N, et al. Among authors: cong x. Bioorg Med Chem Lett. 2014 Aug 1;24(15):3351-5. doi: 10.1016/j.bmcl.2014.05.097. Epub 2014 Jun 6. Bioorg Med Chem Lett. 2014. PMID: 24951334

5

Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors.

Wang Y, Huang W, Xin M, Chen P, Gui L, Zhao X, Zhu X, Luo H, Cong X, Wang J, Liu F. Wang Y, et al. Among authors: cong x. Bioorg Med Chem. 2019 Jun 15;27(12):2592-2597. doi: 10.1016/j.bmc.2019.03.048. Epub 2019 Mar 25. Bioorg Med Chem. 2019. PMID: 30926315

6

Homocysteine ameliorates the endothelium-independent hypoxic vasoconstriction via the suppression of phosphatidylinositol 3-kinase/Akt pathway in porcine coronary arteries.

An YM, Feng H, Zhang XZ, Cong X, Zhao Q, Wu LL, Dou D. An YM, et al. Among authors: cong x. Biochem Biophys Res Commun. 2017 Apr 22;486(1):178-183. doi: 10.1016/j.bbrc.2017.03.022. Epub 2017 Mar 9. Biochem Biophys Res Commun. 2017. PMID: 28285136

7

Chemoselective deprotection of cyclic N,O-aminals using catalytic bismuth(III) bromide in acetonitrile.

Cong X, Hu F, Liu KG, Liao QJ, Yao ZJ. Cong X, et al. J Org Chem. 2005 May 27;70(11):4514-6. doi: 10.1021/jo050228a. J Org Chem. 2005. PMID: 15903335

8

RCM approaches toward the diastereoselective synthesis of vicinal trans-diaminocyclitols from L-serine.

Cong X, Liao QJ, Yao ZJ. Cong X, et al. J Org Chem. 2004 Aug 6;69(16):5314-21. doi: 10.1021/jo0496547. J Org Chem. 2004. PMID: 15287776

9

Decreased PKG transcription mediated by PI3K/Akt/FoxO1 pathway is involved in the development of nitroglycerin tolerance.

An YM, Li YJ, Zhang CL, Cong X, Gao YS, Wu LL, Dou D. An YM, et al. Among authors: cong x. Biochem Biophys Res Commun. 2019 Jan 22;508(4):1195-1201. doi: 10.1016/j.bbrc.2018.12.065. Epub 2018 Dec 14. Biochem Biophys Res Commun. 2019. PMID: 30554658

10

[Activation of transient receptor potential vanilloid subtype 1 serves as a novel pathway to modulate secretion in submandibular gland].

Cong X, Zhang Y, Yu GY, Wu LL. Cong X, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2015 Feb 18;47(1):8-12. Beijing Da Xue Xue Bao Yi Xue Ban. 2015. PMID: 25686321 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,236 results

Search Page

Filters